{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:42Z","timestamp":1761986502770},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-017-1278-3","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T12:26:44Z","timestamp":1493036804000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Faizan","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Imran Mustafa","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsin","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Boigon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Fidler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"1278_CR1","first-page":"426","volume":"48","author":"JM Ellis","year":"1949","unstructured":"Ellis JM. Urticaria pigmentosa; a report of a case with autopsy. Arch Pathol. 1949;48:426\u201335.","journal-title":"Arch Pathol"},{"key":"1278_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/01652176.2004.9695178","volume":"26","author":"W Misdorp","year":"2004","unstructured":"Misdorp W. Mast cells and canine mast cell tumours. A review. Vet Q. 2004;26:156\u201369.","journal-title":"Vet Q"},{"key":"1278_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","volume":"62","author":"WD Travis","year":"1988","unstructured":"Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG. Significance of systemic mast cell disease with associated hematologic disorders. Cancer. 1988;62:965\u201372.","journal-title":"Cancer"},{"key":"1278_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","volume":"61","author":"WD Travis","year":"1986","unstructured":"Travis WD, Li CY, Hoagland HC, Travis LB, Banks PM. Mast cell leukemia: report of a case and review of the literature. Mayo Clin Proc. 1986;61:957\u201366.","journal-title":"Mayo Clin Proc"},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1055\/s-2008-1058826","volume":"119","author":"U Hansen","year":"1994","unstructured":"Hansen U, Wiese R, Knolle J. Shock and coagulation disorders in systemic mastocytosis. Dtsch Med Wochenschr. 1994;119:1231\u20134.","journal-title":"Dtsch Med Wochenschr"},{"key":"1278_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/path.1711770207","volume":"177","author":"T Fukuda","year":"1995","unstructured":"Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil\/mast cell precursors from chronic myelogenous leukaemia. J Pathol. 1995;177:139\u201346.","journal-title":"J Pathol"},{"key":"1278_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00000478-198307000-00005","volume":"7","author":"RD Brunning","year":"1983","unstructured":"Brunning RD, McKenna RW, Rosai J, Parkin JL, Risdall R. Systemic mastocytosis. Extracutaneous manifestations. Am J Surg Pathol. 1983;7:425\u201338.","journal-title":"Am J Surg Pathol"},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF01533368","volume":"14","author":"LB Schwartz","year":"1994","unstructured":"Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol. 1994;14:190\u2013204.","journal-title":"J Clin Immunol"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley Jr","year":"1999","unstructured":"Longley Jr BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, et al. Activating and dominant inactivating c-KIT catalytic domain mutations I distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96:1609\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1365-2141.1995.tb05417.x","volume":"91","author":"L Escribano","year":"1995","unstructured":"Escribano L, Orfao A, Villarrubia J, Cerver\u00f3 C, Velasco JL, Mart\u00edn F, et al. Expression of lymphoid associated antigens in mast cells: report of a case of systemic mast cell disease. Br J Haematol. 1995;91:941\u20133.","journal-title":"Br J Haematol"},{"key":"1278_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00210-016-1247-1","volume":"389","author":"GJ Molderings","year":"2016","unstructured":"Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, et al. Pharmacological treatment options for mast cell activation disease. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:671\u201394.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1278_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/all.12672","volume":"70","author":"UB Nurmatov","year":"2015","unstructured":"Nurmatov UB, Rhatigan E, Simons FE, Sheikh A. H1-antihistamines for primary mast cell activation syndromes: a systematic review. Allergy. 2015;70:1052\u201361.","journal-title":"Allergy"},{"key":"1278_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/BF01536749","volume":"35","author":"P Goldsmith","year":"1990","unstructured":"Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DA. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci. 1990;35:1409\u201313.","journal-title":"Dig Dis Sci"},{"key":"1278_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2133.1995.tb08689.x","volume":"132","author":"E Delaporte","year":"1995","unstructured":"Delaporte E, Pi\u00e9rard E, Wolthers BG, Desreumaux P, Janin A, Cortot A, et al. Interferon alpha in combination with corticosteroids improves systemic mast cell disease. Br J Dermatol. 1995;132:479\u201382.","journal-title":"Br J Dermatol"},{"key":"1278_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1756-8722-4-10","volume":"4","author":"GJ Molderings","year":"2011","unstructured":"Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol. 2011;4:10.","journal-title":"J Hematol Oncol"},{"key":"1278_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","volume":"10","author":"P Bonadonna","year":"2010","unstructured":"Bonadonna P, Zanotti R, M\u00fcller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10:347\u201353.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1278_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2169\/internalmedicine.50.4640","volume":"50","author":"GJ Molderings","year":"2011","unstructured":"Molderings GJ, Raithel M, Kratz F, Azemar M, Haenisch B, Harzer S. Omalizumab treatment of systemic mast cell activation disease: experiences from four cases. Intern Med. 2011;50:611\u20135.","journal-title":"Intern Med"},{"key":"1278_CR18","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1182\/blood.V126.23.5194.5194","volume":"126","author":"LB Afrin","year":"2015","unstructured":"Afrin LB. Utility of Continuous Diphenhydramine Infusion in Severe Mast Cell Activation Syndrome. Blood. 2015;126:5194.","journal-title":"Blood"},{"key":"1278_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/cncr.21996","volume":"107","author":"HJ Droogendijk","year":"2006","unstructured":"Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL. Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial. Cancer. 2006;107:345\u201351.","journal-title":"Cancer"},{"key":"1278_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/ejh.12606","volume":"95","author":"LB Afrin","year":"2015","unstructured":"Afrin LB, Cichocki FM, Patel K, Molderings GJ. Successful treatment of mast cell activation syndrome with sunitinib. Eur J Haematol. 2015;95:595\u20137.","journal-title":"Eur J Haematol"},{"key":"1278_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1525-1470.2011.01576.x","volume":"29","author":"PJ Turner","year":"2012","unstructured":"Turner PJ, Kemp AS, Rogers M, Mehr S. Refractory symptoms successfully treated with leukotriene inhibition in a child with systemic mastocytosis. Pediatr Dermatol. 2012;29:222\u20133.","journal-title":"Pediatr Dermatol"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood-2015-06-649525","volume":"126","author":"C Akin","year":"2015","unstructured":"Akin C. Cladribine for mastocytosis: benefits and risks. Blood. 2015;126:931\u20132.","journal-title":"Blood"},{"key":"1278_CR23","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1200\/JCO.2014.55.2018","volume":"32","author":"C Ustun","year":"2014","unstructured":"Ustun C, Reiter A, Scott BL, Nakamura R, Damaj G, Kreil S, et al. Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol. 2014;32:3264\u201374.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-017-1278-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T04:24:06Z","timestamp":1601958246000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-017-1278-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s13256-017-1278-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"article-number":"119"}}